mentrual irregularity, acne and facial hiar disease study
Phase 2
Completed
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2018/10/015900
- Lead Sponsor
- kouser fathima firdose
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
amenorrhoea and/ or oligomenorrhoea
clinical evidence of hyperandrogenism
PCO on USG
Exclusion Criteria
1.Patients with Insulin sensitizing treatment within 3 months16
2.Patients with Hormonal treatment
3.Patients with H/o DM, Hypertension
4.Pregnant and lactating women. 16
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method menstrual regulationTimepoint: 3 cycles
- Secondary Outcome Measures
Name Time Method change in ovarian morphologyTimepoint: 3 cycles